Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. CRGY
10. AAPL

Go back to Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann

May 14, 2024 6:46 AM EDT

Ladenburg Thalmann analyst Aydin Huseynov raised the price target on Capricor Therapeutics (NASDAQ: CAPR) to $25.00 (from $24.00) while maintaining a Buy rating.

The analyst comments "CAPR seems to have advanced in its regulatory negotiations with the FDA with possible rolling BLA... More

Capricor Therapeutics (CAPR) Misses Q1 EPS by 8c

May 13, 2024 4:11 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q1 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.91 million versus the consensus estimate of $7.05 million.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More